CVE-2022-1517: falha crítica em Illumina iSeq 100 Instrument
3.2.1 EXECUTION WITH UNNECESSARY PRIVILEGES CWE-250
Publicada em · Atualizada em
Aviso por e-mail quando ela entrar no KEV, ganhar PoC pública ou subir de nota.
28Vexday Risk Score
Sem sinal de exploração. Nenhum artefato público de exploração conhecido até agora.
ssvc Trackcvss 10epss 1.8%
LRM utilizes elevated privileges. An unauthenticated malicious actor can upload and execute code remotely at the operating system level, which can allow an attacker to change settings, configurations, software, or access sensitive data on the affected produc. An attacker could also exploit this vulnerability to access APIs not intended for general use and interact through the network.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
Produtos afetados
Illumina · iSeq 100 InstrumentIllumina · MiniSeq InstrumentIllumina · MiSeq DxIllumina · MiSeq InstrumentIllumina · NextSeq 500 InstrumentIllumina · NextSeq 550DxIllumina · NextSeq 550 InstrumentCVEs relacionadas — Illumina iSeq 100 Instrument
No mesmo produto, das mais perigosas para as menos.
CVE-2022-1518CRITICAL3.2.2 IMPROPER LIMITATION OF A PATHNAME TO A RESTRICTED DIRECTORY ('PATH TRAVERSAL') CWE-22EPSS 1.7%CVE-2022-1519CRITICALCVE-2022-1519EPSS 1.4%CVE-2022-1521CRITICAL3.2.4 IMPROPER ACCESS CONTROL CWE-284EPSS 1.1%CVE-2022-1524HIGH3.2.5 CLEARTEXT TRANSMISSION OF SENSITIVE INFORMATION CWE-319EPSS 0.3%